UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT for Amarin Corporation
In a company note published earlier today, Jefferies & Company, Inc. reiterated its Buy rating for Amarin Corporation (NASDAQ: AMRN) and raised its price target from $24.00 to $26.00.
Jefferies & Company went on to say “Yesterday, the patent office (PTO) posted unexpected positive office actions on three key patent applications based on MARINE: the core ‘889 application and two continuation applications ‘408 and '145. We believe these actions should lead to near-term issuance of these patents, which could provide AMR101 protection through 2030. We remain bullish on near-term approval of AMR101.”
Amarin Corporation closed yesterday at $13.16.
Latest Ratings for AMRN
|Feb 2014||Aegis Capital||Maintains||Hold|
|Jan 2014||MKM Partners||Downgrades||Buy||Neutral|
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.